These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3073308)

  • 1. Biological indicators of neurotoxicity in central and peripheral toxic neuropathies.
    Maroni M; Barbieri F
    Neurotoxicol Teratol; 1988; 10(5):479-84. PubMed ID: 3073308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between behavioral and pathological changes in the evaluation of neurotoxicity.
    Broxup B; Robinson K; Losos G; Beyrouty P
    Toxicol Appl Pharmacol; 1989 Dec; 101(3):510-20. PubMed ID: 2603164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarkers of neurotoxic effects induced by environmental chemicals].
    Indulski JA; Lutz W
    Med Pr; 1996; 47(4):383-91. PubMed ID: 8847985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotoxic workshop materials: II. Organic substances--a review of the years 1970 to 1982].
    Triebig G; Braune U
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Oct; 178(3):207-58. PubMed ID: 6362284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological markers as early signs of organophosphate neurotoxicity.
    Nagymajtényi L; Dési I; Lorencz R
    Neurotoxicol Teratol; 1988; 10(5):429-34. PubMed ID: 3247000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological investigation of central, peripheral and autonomic nerve function in workers with long-term low-level exposure to carbon disulphide in the viscose industry.
    Reinhardt F; Drexler H; Bickel A; Claus D; Ulm K; Angerer J; Lehnert G; Neundörfer B
    Int Arch Occup Environ Health; 1997; 70(4):249-56. PubMed ID: 9342625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide.
    Calleman CJ; Wu Y; He F; Tian G; Bergmark E; Zhang S; Deng H; Wang Y; Crofton KM; Fennell T
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):361-71. PubMed ID: 8209389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of central and peripheral nervous system lesions caused by high-dose short-term and low-dose subchronic acrylamide treatment in rats.
    O'Shaughnessy DJ; Losos GJ
    Toxicol Pathol; 1986; 14(4):389-94. PubMed ID: 3809891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron diseases and neurotoxic substances: a possible link?
    Chang PA; Wu YJ
    Chem Biol Interact; 2009 Jul; 180(2):127-30. PubMed ID: 19497409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occupational toxic neuropathies: morphology in peripheral nerve biopsies].
    Scelsi R; Candura SM
    G Ital Med Lav Ergon; 2012; 34(4):410-9. PubMed ID: 23477107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic neuropathies.
    Misra UK; Kalita J
    Neurol India; 2009; 57(6):697-705. PubMed ID: 20139496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of toxic injury in the peripheral nervous system: neuropathologic considerations.
    Jortner BS
    Toxicol Pathol; 2000; 28(1):54-69. PubMed ID: 10668991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem axolemmal protein phosphorylation in vitro in hens dosed with di-1-butyl-2,2-dichlorovinyl phosphate.
    Huggins DJ; Richardson RJ
    J Toxicol Environ Health A; 1999 Feb; 56(4):263-82. PubMed ID: 10706244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of biochemical markers in peripheral body fluids in assessment of human neurotoxicity].
    Huang J; Tanii H; Hashimoto K
    Sangyo Igaku; 1994 Mar; 36(2):71-82. PubMed ID: 7911853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques.
    Hausherr V; Schöbel N; Liebing J; van Thriel C
    Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral and central nervous system lesions caused by triethyl- and trimethyltin salts in rats.
    O'Shaughnessy DJ; Losos GJ
    Toxicol Pathol; 1986; 14(2):141-8. PubMed ID: 3764311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment strategies for neuroprotective agents.
    Slikker W; Gaylor DW
    Ann N Y Acad Sci; 1995 Sep; 765():198-208; discussion 209. PubMed ID: 7486606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanediol, and 2,5-hexanedione alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioate in hens.
    Abou-Donia MB; Makkawy HM; Campbell GM
    J Toxicol Environ Health; 1985; 16(1):85-100. PubMed ID: 4068058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms.
    El-Fawal HA; Waterman SJ; De Feo A; Shamy MY
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):767-75. PubMed ID: 10502543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.